Arcus Biosciences Inc (RCUS)
16.47
+1.40
(+9.29%)
USD |
NYSE |
Jun 03, 11:43
Arcus Biosciences Accounts Payable (Quarterly): 16.00M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 16.00M |
December 31, 2023 | 17.00M |
September 30, 2023 | 17.00M |
June 30, 2023 | 12.00M |
March 31, 2023 | 28.00M |
December 31, 2022 | 20.00M |
September 30, 2022 | 10.55M |
June 30, 2022 | 21.98M |
March 31, 2022 | 18.09M |
December 31, 2021 | 10.00M |
September 30, 2021 | 13.22M |
June 30, 2021 | 16.96M |
March 31, 2021 | 24.54M |
Date | Value |
---|---|
December 31, 2020 | 15.68M |
September 30, 2020 | 8.102M |
June 30, 2020 | 12.05M |
March 31, 2020 | 2.426M |
December 31, 2019 | 4.704M |
September 30, 2019 | 2.905M |
June 30, 2019 | 2.448M |
March 31, 2019 | 2.829M |
December 31, 2018 | 3.102M |
September 30, 2018 | 2.109M |
June 30, 2018 | 5.388M |
March 31, 2018 | 3.92M |
December 31, 2017 | 3.82M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
2.426M
Minimum
Mar 2020
28.00M
Maximum
Mar 2023
13.68M
Average
14.45M
Median
Accounts Payable (Quarterly) Benchmarks
Bristol-Myers Squibb Co | 3.539B |
Gilead Sciences Inc | 622.00M |
Merck & Co Inc | 3.514B |
Pfizer Inc | 5.591B |
Alnylam Pharmaceuticals Inc | 78.15M |